Members

The FDA and Methuselah

 

This article explicitly describes the SENS approach right from the outset, contrasting it with former approaches. This is an encouraging development in the mainstream press coverage of SENS, which usually begins by introducing the prospect of extreme longevity, only mentioning the method parenthetically.

" Aubrey de Grey, a Cambridge University cell biologist and the most prominent champion of engineering, uses the analogy of how some people manage to cruise today's roads in perfectly preserved Model Ts. The car wasn't designed to run for a century. Nothing stopped normal wear and tear every time it was driven. Constant repair and maintenance are what did the trick. De Grey is focusing on seven possible areas of "cellular intervention" to slow aging. But the science is clearly in its infancy. It will stay there forever unless Washington fundamentally changes the way that it licenses drugs. "
 

 

Proceed to the article at Forbes.Com.